The ESCRT protein CHMP5 promotes T cell leukemia by enabling BRD4-p300-dependent transcription

ESCRT蛋白CHMP5通过激活BRD4-p300依赖性转录来促进T细胞白血病。

阅读:3
作者:Katharine Umphred-Wilson ,Shashikala Ratnayake # ,Qianzi Tang # ,Rui Wang # ,Sneha Ghosh Chaudhary ,Devaiah N Ballachanda ,Josephine Trichka ,Jan Wisniewski ,Lan Zhou ,Qingrong Chen ,Daoud Meerzaman ,Dinah S Singer ,Stanley Adoro
Addiction to oncogene-rewired transcriptional networks is a therapeutic vulnerability in cancer cells, underscoring a need to better understand mechanisms that relay oncogene signals to the transcriptional machinery. Here, using human and mouse T cell acute lymphoblastic leukemia (T-ALL) models, we identify an essential requirement for the endosomal sorting complex required for transport protein CHMP5 in T-ALL epigenetic and transcriptional programming. CHMP5 is highly expressed in T-ALL cells where it mediates recruitment of the coactivator BRD4 and the histone acetyl transferase p300 to enhancers and super-enhancers that enable transcription of T-ALL genes. Consequently, CHMP5 depletion causes severe downregulation of critical T-ALL genes, mitigates chemoresistance and impairs T-ALL initiation by oncogenic NOTCH1 in vivo. Altogether, our findings uncover a non-oncogene dependency on CHMP5 that enables T-ALL initiation and maintenance.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。